Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2011
04/13/2011CN101380425B Arthrosis pill
04/13/2011CN101380340B Wall-broken glossy ganoderma spore powder antioxidation method
04/13/2011CN101375852B Boletic acid quetiapine oral preparation and preparation method thereof
04/13/2011CN101366919B Traditional Chinese medicine ointment for treating rheumatism diseases
04/13/2011CN101365433B Iontophoresis preparation
04/13/2011CN101322814B Chinese medicine for treating eczema and preparation thereof
04/13/2011CN101317902B Medical ointment for treating empyrosis, decubitus
04/13/2011CN101313971B Chinese medicine composition for treating nephropathy
04/13/2011CN101306134B Compound Nanxing pain paste and cataplasm combination and its preparation method
04/13/2011CN101288680B Preparation method of instant tuckahoe granule
04/13/2011CN101284029B Pain relieving, hemostasia and antipruritic drug powder
04/13/2011CN101278948B Biological medical membrane and method of preparing the same
04/13/2011CN101254235B Method of preparing extract for curing periodontal diseases
04/13/2011CN101239095B Method for preparing embolism-extinguishing enteric-coated capsule
04/13/2011CN101199804B Powders medicament for treating wean enuresis
04/13/2011CN101199548B Perfluorination carbon emulsion and preparing method thereof
04/13/2011CN101194937B Acupuncture points energy adjusting plaster capable of replacing acupuncture needle and moxa-preparation, and method for preparing the same
04/13/2011CN101190238B Method for using shrimp shell mud fermentation to produce biological calcium product
04/13/2011CN101185670B Tincture medicine for treating ganglion
04/13/2011CN101181063B Nutrition health products for curing male infertility and sex hypofunction as well as preparing method thereof
04/13/2011CN101167875B Traditional Chinese medicinal preparation for treating diabetes and its preparing process
04/13/2011CN101146516B Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
04/13/2011CN101129434B Technique for extracting organic powder of artemisia leaf
04/13/2011CN101125140B Application of dihydroartemisinin in reinforcing chemotherapy medicine antitumor curative effect
04/13/2011CN101112592B Chinese traditional medicine oral liquid for treating women's endocrine dyscrasia four diseases and method for preparing the same
04/13/2011CN101112387B Smectite turbid liquor for treating non-infectious diarrhea and method for preparing the same
04/13/2011CN101095751B Medicinal composition having functions of removing chloasma and improving nutritional anemia and method for preparing the same
04/13/2011CN101062019B Lappaconitine hydrobromide transparent patch and the preparing method thereof
04/13/2011CN101057966B Liposome nanometer carrier situ gel preparation used for eye epidermal growth factor
04/13/2011CN101053641B Baoyuan kidney-invigorating navel plaster
04/13/2011CN101028484B Chinese medicinal paste for treating tumor and its production
04/13/2011CN101028264B Huisanliu tablets as medicine and their preparation
04/13/2011CN101020002B Compound Chinese medicine preparation for assisting tumor radiotherapy and its preparation method
04/12/2011US7923596 Method and system for producing dressing products of polymer fibres useful for covering moist wounds
04/12/2011US7923585 Menthol derivative and cooling agent composition comprising the same
04/12/2011US7923560 Delivery of immune response modifier compounds
04/12/2011US7923548 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1
04/12/2011US7923536 Compositions and methods of delivery of pharmacological agents
04/12/2011US7923534 Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3
04/12/2011US7923509 Drug delivery compositions and medical devices containing block copolymer
04/12/2011US7923469 Compositions including vitamin-based surfactants and methods for using same
04/12/2011US7923453 Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
04/12/2011US7923436 Methods and compounds for controlled release of recombinant parvovirus vectors
04/12/2011US7923042 Medicated gauze
04/12/2011US7923041 Compositions and methods for enhancing cognitive function
04/12/2011US7923038 Method and composition for the treatment of muscular-skeletal and related afflictions
04/12/2011US7923035 Humidity-dependent antibacterial powdery composition, process for producing the same, humidity-dependent antibacterial food storing article and method of storing food
04/12/2011US7923034 Process for producing microparticles
04/12/2011US7923033 comprising protective coatings surrounding the cores containing nutrients, for release into the interstines of ruminants
04/12/2011US7923032 polymer compositions of the invention are biodegradable, non-toxic, and provide sustained delivery of therapeutic agents at an area of interest within the central nervous system
04/12/2011US7923031 Haemostatic sprays and compositions
04/12/2011US7923030 Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
04/12/2011US7923029 Freeze dried particles; respiratory system disorders
04/12/2011US7923028 High dose oral formulation of bisphosphonate and a process for making thereof
04/12/2011US7923027 Ultrasonic cutting of multilayer oral delivery device; aperture connecting core to exterior coating
04/12/2011US7923026 Embedded micellar nanoparticles
04/12/2011US7923025 Pharmaceutical composition for oral use with improved absorption
04/12/2011US7923023 Method and composition for delivery of medicants to animals
04/12/2011CA2554640C Pharmaceutical composition for oral application and method for preparing thereof
04/12/2011CA2543065C Process for the preparation of 1-octene
04/12/2011CA2531504C Transdermal patch incorporating active agent migration barrier layer
04/12/2011CA2502371C Multilayer dosage forms which contain active substances and which comprise a neutral core and an inner and outer coating composed of methacrylate copolymers and methacrylate monomers
04/12/2011CA2498393C Precipitation of solid particles from droplets formed using focused acoustic energy
04/12/2011CA2491398C Processes for preparing triethanolamine salts of low molecular weight heparin and their use in topical creams for antithrombotic therapy
04/12/2011CA2462905C Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease
04/12/2011CA2460867C Nanoparticulate insulin formulations
04/12/2011CA2460649C Novel calixarene based dispersible colloidal systems in the form of nanoparticles
04/12/2011CA2452813C Unimolecular polymeric micelles with an ionizable inner core
04/12/2011CA2446221C Stable powder inhalation dosage formulation
04/12/2011CA2414241C Polymeric micelle compositions
04/12/2011CA2396542C Composition promoting lacrimal secretion
04/12/2011CA2362299C Sheet-form adhesive preparation
04/12/2011CA2277365C Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
04/12/2011CA2185644C Use of green porphyrins in ocular diagnosis and therapy
04/07/2011WO2011041680A2 Compositions and methods of prophylaxis for contact dermatitis
04/07/2011WO2011041642A1 Microparticle compositions and methods for treating age-related macular degeneration
04/07/2011WO2011041640A1 Olopatadine compositions and uses thereof
04/07/2011WO2011041611A1 Cofactors and methods for use for individuals
04/07/2011WO2011041542A2 Herbal pain killer compositions
04/07/2011WO2011041451A2 Smoking cessation with body weight maintenance and nutritional supplement
04/07/2011WO2011041300A1 Reduced-odor polyol composition and method of producing same
04/07/2011WO2011040956A1 Novel pesticide formulations
04/07/2011WO2011040888A1 A biodegradable composition or combination and uses thereof
04/07/2011WO2011040597A1 Pharmaceutical composition containing medicament-containing fine particles and method for producing same
04/07/2011WO2011040572A1 Ophthalmic composition
04/07/2011WO2011040535A1 Hepatitis c virus vaccine composition
04/07/2011WO2011040433A1 Eye drops
04/07/2011WO2011040432A1 Eye wash agent
04/07/2011WO2011040195A1 Unpleasant taste-masking particles and an oral preparation containing same
04/07/2011WO2011040013A1 Novel liquid crystal composition
04/07/2011WO2011039952A1 Method for improving the aqueous solubility of poorly-soluble substances
04/07/2011WO2011039780A2 Topical formulation for diabetic foot ulcers
04/07/2011WO2011039768A2 Pharmaceutical compositions for reducing alcohol-induced dose dumping
04/07/2011WO2011039686A1 Latrepirdine oral sustained release dosage forms
04/07/2011WO2011039680A1 Intrauterine electronic capsule for administering a substance
04/07/2011WO2011039637A2 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
04/07/2011WO2011039527A1 Formulations for c-met kinase inhibitors
04/07/2011WO2011039418A1 An intrauterine system
04/07/2011WO2011039369A2 Amorphous forms of a 2-amino-4-(4-fluorobenzylamino)phenylcarbamate derivative
04/07/2011WO2011039337A1 Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof